Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Pontifax
company
About
Pontifax is a venture capital firm that finances pharmaceutical and life sciences companies.
- 1 - 10
Highlights
Details
- Industries
- Biotechnology,Medical Device,Pharmaceutical,Venture Capital
- Founded date
- Jan 1, 2004
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Investor Type
- Venture Capital
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Investments
Number of Investments
Number of Lead Investments
6
1
Pontifax has made 6 investments. Their most recent investment was on
Sep 14, 2020, when Neogene Therapeutics raised $110M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Sep 14, 2020
Neogene Therapeutics
|
Series A | $110M | Biotechnology | — |
|
Jul 14, 2020
ProQR Therapeutics
|
Post-IPO Debt | $30M | Biotechnology | Yes |
|
Jan 11, 2020
PACT Pharma
|
Series C | $75M | Biotechnology | — |
|
Sep 2, 2019
Adicet Bio
|
Series B | $80M | Biopharma | — |
|
Nov 8, 2017
ArQule
|
Post-IPO Equity | $9.50M | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
